Delivery and Safety of Inhaled Interferon-γ in Idiopathic Pulmonary Fibrosis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Delivery and Safety of Inhaled Interferon-γ in Idiopathic Pulmonary Fibrosis

Published:2012-04 Issue:2 Volume:25 Page:79-87
ISSN:1941-2711
Container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery
language:en
Short-container-title:Journal of Aerosol Medicine and Pulmonary Drug Delivery

Author:

Diaz Keith T.¹,Skaria Shibu¹,Harris Keith¹,Solomita Mario¹,Lau Stephanie²,Bauer Kristy²,Smaldone Gerald C.¹,Condos Rany²

Affiliation:

1. Division of Pulmonary, Critical Care and Sleep Medicine, Department of Medicine, State University of New York, Stony Brook, New York.

2. Division of Pulmonary and Critical Care Medicine, Department of Medicine, New York University School of Medicine, New York, New York.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmaceutical Science,Pulmonary and Respiratory Medicine

Link

http://www.liebertpub.com/doi/pdf/10.1089/jamp.2011.0919

Reference39 articles.

1. Determinants of survival in idiopathic pulmonary fibrosis.

2. Idiopathic Pulmonary Fibrosis

3. Prognostic Significance of Histopathologic Subsets in Idiopathic Pulmonary Fibrosis

4. Double-blind, Placebo-controlled Trial of Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

5. High-Dose Acetylcysteine in Idiopathic Pulmonary Fibrosis

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Xuanfei Baidu Decoction ameliorates bleomycin-elicited idiopathic pulmonary fibrosis in mice by regulating the lung-gut crosstalk via IFNγ/STAT1/STAT3 axis;Phytomedicine;2024-09

2. Activation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosis;eLife;2024-02-01

3. Activation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosis;eLife;2024-02-01

4. Activation of the P2RX7/IL-18 pathway in immune cells attenuates lung fibrosis;2024-01-12

5. Nebulizers: Scope and Application in Pulmonary Drug Delivery System;Indian Journal of Pharmaceutical Sciences;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3